Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

Compare Dexcom Stelo vs Abbott Lingo in 2026. Discover the best over-the-counter CGM with our in-depth review of prices, specs, and app features.
Continuous glucose monitors (CGMs) are no longer limited to traditional diabetes management. Over-the-counter glucose biosensors have made it possible for eligible consumers to observe how meals, physical activity, sleep, and daily routines affect their glucose patterns.
Two prominent products in this category are the Dexcom Stelo and Abbott Lingo. Both are wearable glucose biosensors designed for consumers who want to understand their glucose trends without a prescription. However, their apps, product ecosystems, intended uses, and purchasing options differ.
The Dexcom Stelo emphasizes continuous glucose tracking, personalized insights, and the Dexcom ecosystem. Abbott Lingo combines continuous glucose measurements with its Lingo Count scoring system, meal logging, and habit-building guidance.
This comparison examines their hardware, software, usability, integrations, pricing, and intended users to help you understand which product better matches your requirements.
| Feature | Dexcom Stelo | Abbott Lingo |
|---|---|---|
| Product type | OTC glucose biosensor | OTC glucose biosensor |
| Sensor lifespan | Up to 15 days + 12-hour grace period | Up to 14 days |
| Warm-up time | 30 minutes | 60 minutes |
| Glucose tracking | Continuous | Continuous |
| App experience | Glucose trends, meal logging, personalized insights | Glucose trends, Lingo Count, meal logging and coaching |
| Main focus | Glucose tracking and pattern understanding | Glucose tracking and habit development |
| Health app integrations | Dexcom ecosystem; verify current compatibility | Apple Health and Android Health Connect |
| One-time US purchase | $99 for two sensors | Check current US checkout price |
| Monthly US subscription | $89 | Check current US checkout price |
| Prescription required | No | No |
| Intended audience | Eligible adults not using insulin | Adults 18+ not using insulin |
Specifications and prices should be checked against the current manufacturer listings before publication. Sensor lifespan is a maximum indicated wear period, not a guarantee that every sensor will last that long.
The Dexcom Stelo is an over-the-counter integrated continuous glucose monitoring system developed by Dexcom. It is designed for eligible consumers who want to observe glucose patterns and understand how lifestyle factors influence glucose levels.
Stelo supports up to 15 days of sensor wear, followed by a 12-hour grace period. Its warm-up period is approximately 30 minutes.
The sensor is applied to the back of the upper arm using its applicator. Once activated, it continuously measures glucose in interstitial fluid and communicates with the compatible Stelo smartphone app.
Its longer indicated wear period gives it a slight advantage over Lingo in terms of the maximum duration of an individual sensor session.
The Stelo app provides continuous glucose tracking, meal logging, nutrition information, and personalized insights.
Users can examine how different meals, activities, and lifestyle patterns relate to changes in their glucose readings. The app is designed to help consumers identify patterns rather than simply display isolated glucose measurements.
Dexcom has also expanded the Stelo experience with personalized coaching features. The exact features available can depend on the current app version and service availability.
Dexcom’s US manufacturer store lists the following options:
The subscription offers a lower effective monthly price than purchasing each monthly supply separately.
Stelo may appeal to consumers who prioritize:
Abbott Lingo is a consumer glucose biosensor developed by Abbott. It combines continuous glucose monitoring with an app designed to help users understand how everyday habits influence their glucose patterns.
Rather than focusing exclusively on displaying glucose numbers, Lingo emphasizes translating those measurements into understandable feedback.
The Lingo sensor supports up to 14 days of wear and has a warm-up period of approximately 60 minutes.
The wearable sensor is applied to the back of the upper arm. After activation, it continuously measures glucose in interstitial fluid and sends information to the Lingo smartphone app.
Lingo’s shorter indicated sensor lifespan means users may need to replace the sensor slightly more frequently than Stelo users.
One of Lingo’s most distinctive features is its Lingo Count system.
The app translates glucose responses into a scoring experience intended to help users understand how their daily habits affect glucose patterns.
Users can:
The Lingo experience is designed around learning and behavior modification rather than simply presenting raw glucose graphs.
Lingo supports integration with Apple Health and Android Health Connect.
These integrations allow users to share certain glucose data and import activity information, such as workouts, into the Lingo experience.
An important distinction is that the app does not necessarily synchronize all information in real time. Abbott documents that glucose data shared with these health platforms can be delayed by approximately three hours and provided at five-minute intervals, even though the Lingo app displays minute-by-minute measurements.
Lingo’s pricing should be checked against its current US manufacturer checkout page before publication. Plans and promotional prices can change, so historical prices from earlier comparisons should not be presented as current offers.
Lingo may appeal to consumers who prioritize:
Both devices are designed for continuous wear on the upper arm, but there are differences in their indicated sensor lifespans and warm-up periods.
Stelo supports up to 15 days of wear, while Lingo supports up to 14 days.
Stelo also has a shorter warm-up period:
For consumers who prioritize longer sensor sessions and faster initial activation, Stelo has the advantage on these specifications.
However, actual sensor performance and wear duration can vary. Users should follow the manufacturer’s application, care, and replacement instructions.
Accuracy is an important consideration when evaluating any glucose-monitoring device.
One commonly reported measure in CGM clinical studies is Mean Absolute Relative Difference (MARD). It compares sensor readings with reference glucose measurements across a study population. A lower MARD generally indicates closer agreement within that particular study.
However, MARD values should not be compared casually across different studies. Differences in study populations, reference methods, testing conditions, and protocols can affect the results.
The earlier versions of these articles included conflicting MARD figures for both products. Those figures should not be republished without locating the relevant manufacturer clinical validation documents and confirming that the studies are comparable.
For this reason, this comparison does not declare either product more accurate based on unsupported numerical claims.
Consumers should also remember that CGMs measure glucose in interstitial fluid rather than directly measuring blood glucose.
The software ecosystem is one of the most meaningful differences between these products.
Stelo focuses on glucose tracking, trend visualization, meal logging, nutrition information, and personalized insights.
Dexcom also provides its Clarity ecosystem for eligible compatible systems and users. However, do not assume that every feature available on prescription Dexcom systems is available on Stelo. Verify the current Stelo-specific sharing and integration capabilities before relying on them.
Lingo places greater emphasis on the consumer app experience, including its Lingo Count system, meal logging, personalized feedback, and habit-building challenges.
It also supports Apple Health and Android Health Connect integration. These integrations provide additional ways to combine glucose information with activity and workout data.
Verdict: Lingo has a clearly documented consumer-facing integration with Apple Health and Health Connect. Stelo is attractive to users who prefer Dexcom’s monitoring ecosystem and personalized glucose insights.
Price comparisons should account for the number of sensors supplied, their indicated wear duration, and whether the purchase is a one-time transaction or recurring subscription.
Stelo’s published US pricing is:
| Purchase option | Price |
|---|---|
| One-time two-sensor supply | $99 |
| Monthly subscription | $89 |
| Three-month subscription | $252 |
For Lingo, confirm the current US plan prices directly with Abbott before purchasing or publishing a numerical comparison.
A lower initial purchase price does not automatically mean a lower long-term ownership cost. Consumers should compare the total cost of maintaining continuous coverage over several months.
The better choice depends on how you intend to use glucose-monitoring information.
No. Both are marketed as over-the-counter glucose biosensors in the United States. Users should still check the product’s intended-use requirements and eligibility criteria.
Stelo is indicated for up to 15 days, followed by a 12-hour grace period. Lingo is indicated for up to 14 days. Actual sensor life may vary.
Stelo has an approximately 30-minute warm-up period, compared with approximately 60 minutes for Lingo.
Yes. Abbott documents Apple Health integration. Lingo can share glucose data and import certain health and activity information. Glucose data synchronization may be delayed.
Yes. Lingo supports Android Health Connect integration, allowing certain glucose and activity information to be shared between supported applications.
No. Lingo is not intended to diagnose or manage diabetes. Stelo is intended for specified non-insulin-using populations and should not be used as a substitute for professional medical advice or treatment. Consult a qualified healthcare professional about interpreting readings and making health decisions.
Stelo has a longer indicated individual sensor lifespan and a published subscription option. However, the best long-term option depends on the user’s preferred app experience, ecosystem, eligibility, and total ownership cost.
Dexcom Stelo and Abbott Lingo approach consumer glucose monitoring from different perspectives.
Stelo stands out for its 15-day indicated sensor lifespan, shorter warm-up period, and Dexcom ecosystem. Its published subscription options also provide a straightforward way to estimate recurring costs.
Lingo differentiates itself through its Lingo Count system, habit-building features, and documented Apple Health and Android Health Connect integrations. It is particularly interesting to consumers who prefer guided feedback rather than relying exclusively on glucose graphs.
Our conclusion: Dexcom Stelo is the stronger choice on sensor lifespan and warm-up time, while Abbott Lingo offers a more explicitly habit-focused app experience and broader documented consumer health-platform integrations.
Neither is universally better. The right choice depends on the consumer’s intended use, preferred software experience, and compatibility requirements.
Disclaimer: This article is for informational purposes only and is not medical advice. These products have specific intended-use limitations. Do not use consumer glucose-monitoring devices to diagnose a condition, change medication, or make treatment decisions without guidance from a qualified healthcare professional. Product specifications, availability, compatibility, and prices may change. Check the manufacturers’ latest documentation before purchasing.